According to Merus's latest financial reports and stock price the company's current price-to-sales ratio (TTM) is 63.4323. At the end of 2023 the company had a P/S ratio of 36.1.
Year | P/S ratio | Change |
---|---|---|
2023 | 36.1 | 109.74% |
2022 | 17.2 | -38.81% |
2021 | 28.1 | 52.14% |
2020 | 18.5 | 62.66% |
2019 | 11.4 | 49.63% |
2018 | 7.60 | -50.18% |
2017 | 15.3 | -92.98% |
2016 | 217 |
Company | P/S ratio | P/S ratio differencediff. | Country |
---|---|---|---|
ORIC Pharmaceuticals
ORIC | N/A | N/A | ๐บ๐ธ USA |